Xcout IntelCrinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
Subscribe to see Crinetics Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Crinetics Pharmaceuticals, Inc. at a glance
Crinetics Pharmaceuticals, Inc. is a biotechnology company headquartered in San Diego, United States. It is publicly listed (CRNX) with a market capitalisation of $9B. Xcout tracks 19 named people at Crinetics Pharmaceuticals, Inc., including Tobin C. Schilke (Chief Financial Officer). Xcout recorded 15 job postings from Crinetics Pharmaceuticals, Inc. in the last 90 days.
Crinetics Pharmaceuticals, Inc. leadership
- Tobin C. SchilkeChief Financial Officer
- Alan S. KrasnerChief Endocrinologist
- Adriana CabreChief Human Resources Officer
- Chris RobillardChief Business Officer
- Garlan AdamsChief Legal Officer & Corporate Secretary
- Kea LingoChief Information Officer
13 more named people on record for Crinetics Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Crinetics Pharmaceuticals, Inc.
Xcout recorded 15 job postings from Crinetics Pharmaceuticals, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Crinetics Pharmaceuticals, Inc.'s hiring signals →
Recent Crinetics Pharmaceuticals, Inc. news
- AcquisitionVertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team - Yahoo Finance
- AcquisitionVertex to Acquire Crinetics Pharmaceuticals for $10 Billion - Pharmaceutical Executive
5 corporate events on record, with sources — see the full timeline →
Tech stack
Get Crinetics Pharmaceuticals, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Crinetics Pharmaceuticals, Inc. in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 5 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access